...
首页> 外文期刊>Molecular Neurobiology >Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease
【24h】

Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease

机译:Rab7a和Tau的应变特异性改变的调节响应 - 克雷兹菲尔特-Jakob疾病和阿尔茨海默病

获取原文
获取原文并翻译 | 示例

摘要

There is an increasing demand for the understanding of pathophysiology on neurodegeneration diseases at early stages. Changes in endocytic machinery and the cytoskeleton-associated response are the first alterations observed in Creutzfeldt-Jakob disease (CJD) and Alzheimer's disease AD brain. In this study, we performed a targeted search for endocytic pathway proteins in the different regions of the brain. We found late endosome marker Rab7a which was significantly upregulated in the frontal cortex region in the rapid progressive CJD form (MM1) and rapid progressive AD (rpAD) forms. However, Rab9 expression was significantly downregulated only in CJD-MM1 brain frontal cortex region. In the cerebellum, Rab7a expression showed significant upregulation in both subtype MM1 and VV2 CJD forms, in contrast to Rab9 which showed significant downregulation in both subtype MM1 and VV2 CJD forms at terminal stage of the disease. To check regulatory response at pre-symptomatic stage of the disease, we checked the regulatory interactive response of Rab7a, Rab9, and known biomarkers PrPC and tau forms in frontal cortex at pre-symptomatic stage of the disease in tg340 mice expressing about fourfold of human PrP-M129 with PrP-null background that had been inoculated with human sCJD MM1 brain tissue homogenates (sCJD MM1 mice). In addition, we analyzed 5XFAD mice, exhibiting five mutations in the APP and presenilin genes related to familial Alzheimer's disease (FAD), to validate specific regulatory response of Rab7a, Rab9, tau, and phosphorylated form of tau by immunostaining 5XFAD mice in comparison with the wild-type age-matched mice brain. The cortical region of 5XFAD mice brain showed accumulated form of Rab7a in puncta that co-label for p-Tau, indicating colocalization by using confocal laser-scanning microscopy and was confirmed by using reverse co-immunoprecipitation. Furthermore, synthetic RNA (siRNA) against the Rab7a gene decreased expression of Rab7a protein, in cortical primary neuronal cultures of PrPC wild type. This depleted expression of Rab7a led to the increased accumulation of PrPC in Rab9-positive endosomal compartments and consequently an increased co-localization between PrPC/Rab9; however, total tau level decreased. Interestingly, siRNA against tau gene in cortical primary neuronal cultures of PrPC wild-type mice showed enhanced Rab7a and Rab9 expression and increase formation of dendritic spines. The work described highlighted the selective involvement of late endosomal compartment marker Rab7a in CJD, slow and rapid progressive forms of AD pathogenesis.
机译:对早期阶段的神经变性疾病的病理生理学越来越大。内吞机械和细胞骨架相关反应的变化是克雷兹菲尔特 - 雅各(CJD)和Alzheimer疾病广告中观察到的第一次改变。在这项研究中,我们对大脑的不同区域进行了针对性途径蛋白的目标搜索。我们发现晚期内体标记Rab7a,其在快速渐进的CJD形式(MM1)和快速渐进式广告(RPAD)形式中,在额叶区域中显着上调。然而,仅在CJD-MM1脑额叶区域中显着下调RAB9表达。在小脑中,Rab7a表达在亚型MM1和VV2 CJD中表现出显着的上调,与RAB9相反,其在疾病的末期阶段亚型MM1和VV2 CJD形式中显示出显着下调。检查在疾病前症状阶段的监管响应,我们检查了rab7a,rab9和已知的生物标志物Prpc和tau的调节互动响应,在表达疾病的疾病前阶段的疾病前阶段表达了大约四倍的人类PRP-M129与PrP-Null背景接种人SCJD MM1脑组织匀浆(SCJD MM1小鼠)。此外,我们分析了5xFAD小鼠,在与家族性阿尔茨海默病(FAD)相关的APP和PRESENILIN基因中,以通过免疫染色5xFAD小鼠验证Rab7a,Rab9,Tau和磷酸化形式的特异性调节响应。野生型年龄匹配的小鼠脑。 5xFAD小鼠脑的皮质区域显示在PUDCTA中的Rab7a的累积形式,其为p-tau的共同标记,通过使用共聚焦激光扫描显微镜来表明分层化,并通过使用反向共免疫沉淀来证实。此外,对Rab7a基因的合成RNA(siRNA)降低了PRPC野生型皮质原代神经元培养物中Rab7a蛋白的表达。这种毛线的表达Lab7a导致PrPC在RAB9阳性内体隔室中增加的增加,因此PrPC / RAB9之间的共同定位增加;但是,TAU的总水平降低。有趣的是,PRPC野生型小鼠皮质原发性神经元培养中的SiRNA对TAB基因进行了增强的Rab7a和Rab9表达和树突刺的增加。该工作所描述的突出显示晚期内体隔室标志物Rab7a以CJD,缓慢和快速进展形式的AD发病机构的选择性参与。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号